Author Year Type AA (control) AG (control) GG (control AA (case) AG (case) GG (case) G (control) A (control G (case) A (case) HWE
Gu 2010 Hepatocellular 51 166 150 45 179 183 268 466 269 545 YES
Hu 2010 Hepatocellular 106 380 367 79 376 399 592 1114 534 1174 YES
Hadinia 2007 Gastric 24 13 6 117 59 14 25 61 87 293 YES
Mahajan 2008 Gastric 89 153 59 152 189 70 331 271 493 329 YES
Hou 2010 Gastric 100 55 107 41 70 94 269 255 258 152 YES
Sun 2008 Gastric 60 235 235 39 209 282 355 705 287 773 YES
Qi 2010 Colorectal 4 60 60 45 179 183 68 180 269 545 YES
Solerio 2005 Colorectal 76 43 13 128 91 19 195 69 347 129 YES
Hadinia 2007 Colonrectal 52 47 6 117 59 14 59 151 87 293 YES
Cozar 2007 Colorectal 119 87 15 78 77 21 325 117 233 119 YES
Dilmec 2008 Colorectal 36 19 1 108 43 11 21 91 65 259 YES
Cheng 2011 Esphogaous 36 79 90 46 105 54 259 151 213 197 YES
Sun 2008 Esphogaous 128 434 448 73 406 529 690 1330 552 1464 YES
Kammerer 2010 Oral 35 32 16 11 23 6 102 64 45 35 YES
Wong 2006 Oral 12 58 48 25 64 58 82 154 114 180 YES
Yang 2012 Pancreatric 50 178 140 70 374 482 458 278 1338 514 YES
Lang 2012 Pancreatric 82 312 208 62 326 263 728 476 852 450 YES
Table 2: Distribution of CTLA-4 + 49G/A polymorphism among cancer cases and controls in this meta-analysis.
 
Goto home»